Rozerem Takeda Pharmaceuticals North America, Inc. - Treatment for Insomnia
Rozerem is the first and only prescription sleep medication that has shown no evidence of abuse and dependence, and is therefore not designated as a controlled substance. Rozerem is indicated for the treatment of adults with insomnia characterized by difficulty with sleep onset, and can be prescribed for long-term use. Aczone (dapsone) Gel 5%Posted: July 2005
Related Articles:
- Takeda Submits New Drug Application for Ramelteon, an Investigational Sleep Drug - September 24, 2004
